Intervention effect of Qufeng Gutong Cataplasm on myofascial pain syndrome in rats and its mechanism.
10.19540/j.cnki.cjcmm.20230210.401
- Author:
Xue-Ying TAO
1
;
Chao WANG
1
;
Feng-Yu HUANG
1
;
Xin-Zhuo ZHANG
1
;
Chun-Fang LIU
1
;
Xiao-Hui SU
1
;
Na LIN
1
Author Information
1. Institute of Chinese Materia Medica, China Academy of Chinese Medicine Sciences Beijing 100700, China.
- Publication Type:Journal Article
- Keywords:
PI3K/Akt signaling pathway;
Qufeng Gutong Cataplasm;
TRPV1;
inflammatory pain;
myofascial pain syndrome(MPS)
- MeSH:
Rats;
Male;
Animals;
Proto-Oncogene Proteins c-akt;
Rats, Sprague-Dawley;
Tumor Necrosis Factor-alpha;
Phosphatidylinositol 3-Kinases;
Myofascial Pain Syndromes/drug therapy*;
Pain
- From:
China Journal of Chinese Materia Medica
2023;48(14):3855-3864
- CountryChina
- Language:Chinese
-
Abstract:
This paper aims to investigate the intervention effect of Qufeng Gutong Cataplasm(QFGT) on myofascial pain syndrome(MPS) in rats and to preliminarily explain its mechanism from the perspective of improving muscle inflammation and pain. Male SD rats were divided into 6 groups, namely normal group, model group, positive control drug(Huoxue Zhitong Ointment, HXZT) group, and low, medium, and high-dose QFGT groups(75, 150, and 300 mg·d~(-1)). The rat model of MPS was established by striking combined with centrifugation for 8 weeks, during which QFGT and HXZT were used for corresponding intervention. Standard VonFrey fiber was used to evaluate the mechanical pain threshold, and acetone was used to detect the cold pain threshold. The electrophysiological activity of muscle at trigger point was detected, and the electromuscular analysis of trigger point was performed. CatWalk gait analyzer was used to detect pain-induced gait adaptation changes. The hematoxylin-eosin(HE) staining was used to observe the pathological changes in muscle and skin tissues at the trigger point of rats. Immunohistochemistry was used to detect the expression of capsaicin receptor transient receptor potential vanilloid 1(TRPV1) in muscle tissues and interleukin(IL)-33 in skin tissues at the trigger point. The protein expression levels of TRPV1, protein kinase B(Akt), phosphorylated protein kinase B(p-Akt), IL-1β, and tumor necrosis factor-α(TNF-α) in muscle tissues at the trigger point were detected by Western blot. The results showed that as compared with the model group, the mechanical pain threshold and cold pain threshold of rats in other groups were increased after treatment with QFGT. The spontaneous electromyography(EMG) activity was observed in the model group, but QFGT alleviated the EMG activity in a dose-dependent manner. Gait analysis showed that standing duration, average intensity, swing speed, maximum contact point, maximum contact area, paw print length, paw print width, and paw print area were significantly improved in all QFGT groups. Pathological results showed that the disorder of muscle arrangement at the trigger point was decreased, muscle fiber adhesion and atrophy were reduced, and inflammatory cell infiltration was alleviated after treatment with QFGT. In addition, QFGT and HXZT both inhibited the protein expression of TRPV1, PI3K, Akt, p-Akt, IL-1β, and TNF-α in the muscle tissues of rats with MPS. However, there was no significant difference in the pathological structure and expression of IL-33 in the treated skin as compared with the normal group. The related results have proved that QFGT can inhibit the release of inflammatory factors by inhibiting the TRPV1/PI3K/Akt signaling pathway in the muscle trigger point of rats with MPS and finally attenuate the atrophy and adhesion of local muscles and inflammatory infiltration, thereby relieving the muscle pain of rats with MPS, and local administration has no skin irritation.
